In breast cancer tissue sections we found robust co-expression of ZEB1 and HAS2 in tumor cell areas, whereas tumor cells missing ZEB1 were also negative for HAS2 (Figure 2D, Supplementary Figure S2B). This evidence concerns the gene ZEB1 and neoplasm.